Perspective Therapeutics Statistics
Total Valuation
CATX has a market cap or net worth of $285.17 million. The enterprise value is $101.62 million.
Important Dates
The last earnings date was Wednesday, August 13, 2025, before market open.
| Earnings Date | Aug 13, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
CATX has 74.26 million shares outstanding. The number of shares has increased by 67.21% in one year.
| Current Share Class | 74.26M |
| Shares Outstanding | 74.26M |
| Shares Change (YoY) | +67.21% |
| Shares Change (QoQ) | +2.60% |
| Owned by Insiders (%) | 4.86% |
| Owned by Institutions (%) | 61.99% |
| Float | 58.94M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 227.48 |
| Forward PS | n/a |
| PB Ratio | 1.09 |
| P/TBV Ratio | 1.34 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 82.28 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 15.09, with a Debt / Equity ratio of 0.01.
| Current Ratio | 15.09 |
| Quick Ratio | 14.77 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -351.44 |
Financial Efficiency
Return on equity (ROE) is -31.47% and return on invested capital (ROIC) is -17.38%.
| Return on Equity (ROE) | -31.47% |
| Return on Assets (ROA) | -15.32% |
| Return on Invested Capital (ROIC) | -17.38% |
| Return on Capital Employed (ROCE) | -28.68% |
| Revenue Per Employee | $8,821 |
| Profits Per Employee | -$678,236 |
| Employee Count | 140 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -2.10M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -69.48% in the last 52 weeks. The beta is 1.18, so CATX's price volatility has been higher than the market average.
| Beta (5Y) | 1.18 |
| 52-Week Price Change | -69.48% |
| 50-Day Moving Average | 3.74 |
| 200-Day Moving Average | 3.81 |
| Relative Strength Index (RSI) | 52.12 |
| Average Volume (20 Days) | 726,142 |
Short Selling Information
The latest short interest is 6.50 million, so 8.75% of the outstanding shares have been sold short.
| Short Interest | 6.50M |
| Short Previous Month | 6.24M |
| Short % of Shares Out | 8.75% |
| Short % of Float | 11.02% |
| Short Ratio (days to cover) | 6.72 |
Income Statement
In the last 12 months, CATX had revenue of $1.24 million and -$94.95 million in losses. Loss per share was -$1.32.
| Revenue | 1.24M |
| Gross Profit | -51.09M |
| Operating Income | -85.40M |
| Pretax Income | -50.57M |
| Net Income | -94.95M |
| EBITDA | -82.56M |
| EBIT | -85.40M |
| Loss Per Share | -$1.32 |
Full Income StatementBalance Sheet
The company has $191.58 million in cash and $3.57 million in debt, giving a net cash position of $188.01 million or $2.53 per share.
| Cash & Cash Equivalents | 191.58M |
| Total Debt | 3.57M |
| Net Cash | 188.01M |
| Net Cash Per Share | $2.53 |
| Equity (Book Value) | 265.69M |
| Book Value Per Share | 3.58 |
| Working Capital | 182.97M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$64.78 million and capital expenditures -$50.01 million, giving a free cash flow of -$114.78 million.
| Operating Cash Flow | -64.78M |
| Capital Expenditures | -50.01M |
| Free Cash Flow | -114.78M |
| FCF Per Share | -$1.55 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -6,914.98% |
| Pretax Margin | -7,899.92% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CATX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -67.21% |
| Shareholder Yield | -67.21% |
| Earnings Yield | -32.78% |
| FCF Yield | -39.63% |
Analyst Forecast
The average price target for CATX is $12.90, which is 235.94% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $12.90 |
| Price Target Difference | 235.94% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 11 |
| Revenue Growth Forecast (5Y) | 170.25% |
| EPS Growth Forecast (5Y) | -0.27% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 17, 2024. It was a reverse split with a ratio of 1:10.
| Last Split Date | Jun 17, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
CATX has an Altman Z-Score of 4.82 and a Piotroski F-Score of 2.
| Altman Z-Score | 4.82 |
| Piotroski F-Score | 2 |
